Christopher Ryan Sullivan - Dec 10, 2021 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Chief Accounting Officer
Signature
/s/ Jennifer Zoltoski, by Power of Attorney
Stock symbol
AVTX
Transactions as of
Dec 10, 2021
Transactions value $
$1,499
Form type
4
Date filed
12/14/2021, 04:17 PM
Next filing
Mar 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common Stock Purchase $1.5K +955 +11.86% $1.57 9K Dec 10, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.